|
N(omega),N(omega)-dimethyl-L-arginine metabolic process
|
GO_2001298 |
[The chemical reactions and pathways involving N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.] |
|
N(omega)-methyl-L-arginine catabolic process
|
GO_2001297 |
[The chemical reactions and pathways resulting in the breakdown of N(omega)-methyl-L-arginine.] |
|
N(omega)-methyl-L-arginine metabolic process
|
GO_2001296 |
[The chemical reactions and pathways involving N(omega)-methyl-L-arginine.] |
|
malonyl-CoA biosynthetic process
|
GO_2001295 |
[The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.] |
|
malonyl-CoA metabolic process
|
GO_2001293 |
[The chemical reactions and pathways involving malonyl-CoA, the S-malonyl derivative of coenzyme A.] |
|
N(omega),N(omega)-dimethyl-L-arginine catabolic process
|
GO_2001299 |
[The chemical reactions and pathways resulting in the breakdown of N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.] |
|
hydroperoxide metabolic process
|
GO_2001290 |
[The chemical reactions and pathways involving a hydroperoxide.] |
|
malonyl-CoA catabolic process
|
GO_2001294 |
[The chemical reactions and pathways resulting in the breakdown of malonyl-CoA, the S-malonyl derivative of coenzyme A.] |
|
codeine catabolic process
|
GO_2001292 |
[The chemical reactions and pathways resulting in the breakdown of codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.] |
|
codeine metabolic process
|
GO_2001291 |
[The chemical reactions and pathways involving codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.] |
|
regulation of L-leucine biosynthetic process
|
GO_2001276 |
[Any process that modulates the frequency, rate or extent of L-leucine biosynthetic process.] |
|
obsolete positive regulation of glucose import in response to insulin stimulus
|
GO_2001275 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus.] |
|
obsolete negative regulation of glucose import in response to insulin stimulus
|
GO_2001274 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of glucose import in response to insulin stimulus.] |
|
obsolete regulation of glucose import in response to insulin stimulus
|
GO_2001273 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of glucose import in response to insulin stimulus.] |
|
positive regulation of L-leucine biosynthetic process
|
GO_2001278 |
[Any process that activates or increases the frequency, rate or extent of L-leucine biosynthetic process.] |
|
negative regulation of L-leucine biosynthetic process
|
GO_2001277 |
[Any process that stops, prevents or reduces the frequency, rate or extent of L-leucine biosynthetic process.] |
|
obsolete positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
|
GO_2001272 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.] |
|
obsolete negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
|
GO_2001271 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.] |
|
obsolete regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
|
GO_2001270 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.] |
|
negative regulation of caveolin-mediated endocytosis
|
GO_2001287 |
[Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis.] |